Biotin-dependent enzymes contain a biotinyl-lysine residue in a conserved sequence motif, MKM, located in a surface hairpin turn in one of the two β-sheets that make up the domain. A subgene encoding the 82-residue C-terminal biotinyl domain from the biotin carboxy carrier protein of acetyl-CoA carboxylase from Escherichia coli as a fusion protein with glutathione Stransferase was created and over-expressed in E. coli. The biotinyl domain was readily released by cleavage with thrombin. Five mutant domains were created in which the conserved MKM motif was systematically replaced : by MAK and KAM, in which the target lysine is moved one place ; by KKM and MKK, in which a second potential site for biotinylation is introduced ; and by DKA, the motif found in the correspondingly conserved site of lipoylation in the structurally related lipoyl domains of 2-oxo acid dehydrogenase multienzyme complexes. No biotinylation of the MAK or KAM mutants was observed in i o or by purified biotinyl protein ligase in itro ; in the KKM and MKK mutants,
INTRODUCTION
Biotin carboxy carrier protein (BCCP) is one of the three functional subunits in the acetyl-CoA carboxylase of Escherichia coli. This enzyme catalyses the biotin-dependent carboxylation of acetyl-CoA to malonyl-CoA, the first committed step in the biosynthesis of fatty acids [1] . BCCP is a homodimer [2] , each polypeptide chain containing 156 amino acid residues, as deduced from the DNA sequence of the corresponding gene [3] . The biotinyl group is attached post-translationally by the action of a biotinyl protein ligase (BPL, also known as biotin holoenzyme synthetase), which catalyses the formation of an amide linkage between the carboxy group of the biotin and the N '-amino group of a specific lysine residue in BCCP. The biotinyl-lysine (biocytin) residue is located in the C-terminal region of the BCCP protein, in an independently folded domain of about 80 amino acids [4] [5] [6] , the structure of which has been established independently by means of X-ray crystallography [7] and, in solution, by means of NMR spectroscopy (E. L. Roberts, R. W. Broadhurst, M. J. Howard, A. Chapman-Smith, J. E. Cronan, J. C. Wallace and R. N. Perham, unpublished work).
The structure of the biotinyl domain is that of a flattened β-barrel, comprising two 4-stranded β-sheets, with the N-and Cterminal residues close together in space in one sheet and the biotinyl-lysine residue located in a highly conserved MKM only one lysine residue, presumed to be that in its native position in the hairpin turn, was found to be biotinylated in i o and in itro. The DKA mutant was not biotinylated in i o, but was partly lipoylated and octanoylated. It was also a poor substrate for lipoylation in itro catalysed by the E. coli lipoyl protein ligase encoded by the lplA gene. The flanking sequence in the MKM motif is important, but not crucial, and appears to have been conserved in part to be compatible with the subsequent carboxylation reactions of biotin-dependent enzymes. The DKA motif, displayed in the hairpin loop, is sufficient to address lipoylation in E. coli but probably by a pathway different from that mediated by the lplA-dependent ligase. The recognition of the structurally homologous lipoyl and biotinyl domains by the appropriate ligase evidently has a major structural component to it, notably the positioning of the target lysine residue in the exposed hairpin loop, but there appear to be additional recognition sites elsewhere on the domains. sequence in an exposed β-turn in the other sheet ( Figure 1 ). The biotinyl-lysine residue is thus well placed to act as a swinging arm in the mechanism of acetyl-CoA carboxylase, becoming carboxylated at the active site of the biotin carboxylase subunit and passing on the carboxy group at the active site of the carboxytransferase subunit. In E. coli, BCCP is the only biotinylated protein, but a comparable domain with a similar function in the catalytic mechanism is present in all biotindependent enzymes [8, 9] . As predicted previously and despite minimal amino acid sequence similarity [10] , the structure of the biotinyl domain closely resembles that of the lipoyl domain in the dihydrolipoyl acyltransferase component of 2-oxo acid dehydrogenase multienzyme complexes [11, 12] . The lipoyl domain also consists of two 4-stranded β-sheets, with the lipoylated lysine residue prominently displayed in a highly conserved DKA sequence at the tip of the single β-turn in the β-sheet opposite the N-and C-terminal residues [13] [14] [15] [16] [17] . In these enzymes too, the modified (lipoylated) lysine residue functions as a swinging arm ferrying substrate between the three active sites in the enzyme complex.
In E. coli, BPL is encoded by the birA gene [18, 19] , which has been sequenced [20] . The X-ray crystal structure of BPL, which also acts as a repressor of the biotin operon, has been solved [21] . The catalytic mechanism of the enzyme involves a two-step process : activation of the carboxy group of biotin by reaction The two 4-stranded β-sheets are indicated in dark and light-shading, and the MKM motif in the hairpin loop housing the biotinyl-lysine residue (Lys-50) is indicated. The structure is taken from the coordinates of Athappilly and Hendrickson [7] and the Figure was constructed using the program MOLSCRIPT [7a] .
with ATP to form biotin-5h-AMP and elimination of pyrophosphate, followed by transfer of the biotinyl group to the target lysine residue of BCCP and release of AMP. The biotin5h-AMP, bound to BPL, acts as the co-repressor of the biotin operon, which creates an elegant model for the regulation of biotin biosynthesis [22] .
A similar system exists for the post-translational modification of lipoyl domains. In E. coli two genes (lplA and lipB) have been postulated to encode independent pathways for the attachment of the lipoyl group to the apo-protein [23] . The lplA gene has been cloned and over-expressed [24] and the product, lipoyl protein ligase (LPL), catalyses a reaction corresponding to that of BPL, but with lipoyl-5h-AMP as the reaction intermediate. It utilizes exogenous -lipoic acid as its preferred substrate but can use octanoic acid and -lipoic acid [25] , corresponding to the B form of the enzyme described previously [26] . In contrast, the product of the lipB gene relies on an endogenous source of lipoic acid supplied by the lipA-dependent biosynthetic route [23] and is likely to be responsible for most of the aberrant octanoylation of lipoyl domains that occurs under conditions of lipoic acid deficiency [27, 28] .
Two important questions present themselves in the light of the above findings. How do the BPL and LPL enzymes distinguish biotinyl and lipoyl apo-domains as substrates for biotinylation and lipoylation, respectively ? And how are the target lysine residues in the biotinyl and lipoyl domains selected for posttranslational modification ? We have shown previously that the positioning of the target lysine residue at the tip of the β-turn in the lipoyl domain, rather than the conserved DKA sequence in which it is found, plays a dominant role in the targetting process in i o [29] . In this paper, we describe experiments in i o and in itro which demonstrate that placing the target lysine residue at the tip of the β-turn in the biotinyl domain is likewise essential for its post-translational modification by BPL and that the highly conserved MKM sequence is of lesser importance. Importing the DKA motif from the β-turn of the lipoyl domain in place of the MKM motif in the biotinyl domain renders the latter ineffective as a substrate for BPL but confers on it the ability to become lipoylated, albeit poorly. The results throw new light on the specificities of BPL and LPL and the pattern of differing recognition signals displayed by lipoyl and biotinyl domains to ensure correct post-translational modification, which is essential to their biological activity.
MATERIALS AND METHODS

Materials
All chemicals used in the preparation of buffers and solutions were of reagent grade. Bacteriological media were purchased from Oxoid, Unipath Laboratories. E. coli host strain XL1-Blue was from Stratagene. E. coli host strains BL21(DE3) and BL21(DE3)plysS and the expression vector pET11c were from Novagen. Plasmid pGEX-2T was purchased from Pharmacia Biotech. -Lipoic acid, octanoic acid, d-biotin and PMSF were purchased from Sigma, ATP was from Boehringer Mannheim, and isopropyl 1-thio-β-galactopyranoside (IPTG) and dithiothreitol (DTT) were from Melford Laboratories Ltd. Restriction endonucleases and DNA-modifying enzymes were from Pharmacia Biotech ; Pfu DNA polymerase was purchased from Stratagene Ltd. Oligonucleotide primers were synthesized by Mr. M. Weldon in the Protein and Nucleic Acid Facility, Department of Biochemistry, University of Cambridge, Cambridge, U.K.
DNA manipulations
Standard protocols for molecular biology were used as described elsewhere [30] . DNA fragments were purified after agarose gel electrophoresis using a Geneclean2 kit (BIO101). The Quiagen plasmid kit and the Wizard TM DNA purification kit from Promega were used for plasmid isolation. Automated DNA sequence analysis was carried out by Mr. J. Lester and Mrs. K. Pennock (Department of Biochemistry, University of Cambridge, Cambridge, U.K.) using the Prism TM Ready Reaction DyeDeoxy TM Terminator and the Catalyst 800 Molecular Biology Labstation, as described by the manufacturer (Applied Biosystems Inc.). Sequence data were analysed by the seqEd4 analysis software (Applied Biosystems Inc.). PCRs were carried out under mineral oil in a volume of 100 µl. The reaction mixtures contained 200 µM dNTPs, 2 mM MgCl # , 100 pmol each of sense and anti-sense primers, DNA template (amount as stated) and 2n5 units of Pfu DNA polymerase. PCR parameters were : 5 min at 94 mC (1 cycle) ; 1 min at 94 mC, 1 min 30 s at 55 mC, 2 min at 72 mC (25 cycles) ; and 10 min at 72 mC (1 cycle).
Construction of the expression system for the biotinyl domaian
The region of the gene encoding the biotinyl domain of E. coli BCCP was amplified by PCR using 250 ng of E. coli genomic DNA as template and the oligonucleotides Dbccp and Rbccp as primers. Dbccp, 5h-AGCGGATCCGCAGCGGAAATCAGT-GGTCACATC, primes on the coding strand and contains a BamHI cleavage site (underlined) ; Rbccp, 5h-GTTCGAATTC TTACTCGATGACGACCAGCGGCTC, primes on the noncoding strand and carries an EcoRI site (underlined) and a stop codon (in bold). After digestion of the purified PCR product with BamHI and EcoRI, the resulting 255 bp DNA fragment was The oligonucleotide sequences encoding the biocytin motif are indicated in bold.
Mutant
Oligonucleotide
cloned into pGEX-2T, to express the biotinyl domain as a fusion protein with glutathione S-transferase (GST). The resulting plasmid (pGwtBCCP) was propagated in E. coli XL1-Blue cells, and the DNA sequence encoding the entire biotinyl domain was checked on both strands to verify its identity.
Directed mutagenesis of biotinyl domains by overlap extension PCR
The mutant biotinyl domains MAK, KAM, MKK, KKM and DKA were generated by overlap extension PCR [31] . For each mutant, three PCR fragments were obtained : the upstream PCR fragment, the downstream PCR fragment and the overlapping PCR extension fragment. In addition, a pair of sense and antisense oligonucleotides overlapping on their 3h-ends (20-25 bp) were required for each mutant (Table 1) . These oligonucleotides primed in the region to be modified and encoded the appropriate changes of amino acid residue (Table 1) . Upstream PCR fragments were obtained using the Dbccp oligonucleotide (described above) and the anti-sense oligonucletides listed in Table 1 as primers. Downstream PCR fragments were obtained using the sense oligonucleotides (Table 1 ) and the Rbccp oligonucleotide (described above) as primers. Downstream and upstream PCR reactions were carried out using 25 ng of pGwtBCCP plasmid DNA as template. Overlapping extension PCRs to generate the entire mutated sub-genes were performed using 20 ng of the appropriate purified downstream and upstream PCR fragments as template, and the oligonucleotides Dbccp and Rbccp as primers. The overlapping fragments were purified after agarose gel electrophoresis, digested with BamHI and EcoRI, and then cloned into pGEX-2T cut with the same enzymes. In this way five plasmids were generated (pGkamBCCP, pGmakBCCP, pGkkmBCCP, pGmkkBCCP and pGdkaBCCP), each encoding a mutated biotinyl domain. The plasmids were propagated in E. coli XL1-Blue cells and the DNA sequences of the sub-genes were all verified.
Expression and purification of recombinant wild-type and mutant biotinyl domains
E. coli BL21(DE3) cells transformed with the plasmids bearing the wild-type and mutated sub-genes were grown in LB medium [30] containing 100 µg\ml ampicillin and 10 mg\l d-biotin, and the cells were induced at an A '!! of 0n7-0n8 with IPTG (final concentration 1 mM). The cultures were grown for a further 3-6 h and harvested by centrifugation. The cells were washed in PBS [30] , resuspended in 10 ml of PBS containing 1 mM PMSF, disrupted (131i10' Pa) in a French press (SLM-AMINCO) and the cell debris removed by centrifugation (15 000 g for 1 h at 4 mC). Samples were then loaded on to a Pharmacia Glutathione 4B Sepharose2 affinity column (1n6 cmi10 cm ; flow rate 0n4 ml\min) equilibrated with PBS. The column was washed with the same buffer until a stable base line (A #)! ) was reached, and 100 units of thrombin (Calbiochem-Novabiochem Corporation) in 5 ml of PBS were then loaded on to the column (flow rate 1 ml\min). The column was incubated at 37 mC for 2 h and the recombinant biotinyl domain released by thrombin cleavage was then eluted from the column with PBS (100 ml) at a flow rate of 1 ml\min. Fractions (2 ml) containing the protein domain were concentrated using Centriprep-3 concentrators (Amicon) and loaded (in 2 ml batches) on to a Pharmacia Superdex TM 30 HR 16\60 gel filtration column (flow rate 1 ml\min) previously equilibrated with 20 mM potassium phosphate buffer, pH 7n0. Fractions containing the protein domain were pooled, concentrated and stored at k80 mC for future use.
Anion-exchange chromatography of wild-type and mutant biotinyl domains
Further purification of the recombinant domains was carried out by anion-exchange chromatography on a Pharmacia Resource TM Q HR 16\10 column. Protein domains were loaded on to the column (flow rate 5 ml\min) previously equilibrated with 20 mM potassium phosphate (buffer A), pH 7n5, for purification of the wild-type biotinyl domain ; pH 7n0 for the DKA mutant ; and pH 8n0 for the KKM and MKK mutants. Biotinylated and unbiotinylated forms of the recombinant domains were resolved by applying a linear gradient (80 ml) of 0n1-0n2 M NaCl at a flow rate of 5 ml\min. Fractions (1 ml) of interest were pooled, dialysed against buffer A, pH 7n0, concentrated and stored at k80 mC.
Expression and purification of BPL
BPL was purified from E. coli BL21(DE3)plysS cells transformed with the plasmid pTbpl (P. Reche and R. N. Perham, unpublished work). pTbpl was derived from the plasmid pMBR10 [32] and carries the gene encoding the BPL of E. coli under the T7lac promoter in pET11c. Cells were grown in LB medium containing 100 µg\ml ampicillin and at an A '!! of 0n6-0n8 were induced with IPTG (final concentration 1 mM). Cells were harvested by centrifugation and resuspended in 50 mM Tris\ HCl, pH 8n2, containing 100 mM KCl, 1 mM DTT, 0n1 mM EDTA and 5 % glycerol (buffer B). The cells were disrupted in a French press and the cell-free extract was applied to a Pharmacia Hiload TM Q HR 16\10 anion-exchange column (flow rate 2n5 ml\min). The recombinant protein was eluted with a linear gradient (70 ml) of 0-1 M KCl in buffer B at a flow rate of 2n5 ml\min. Fractions (2n5 ml) containing the protein of interest were pooled, concentrated (using a Centriprep-10 from Amicon) and loaded on to a Pharmacia Superdex TM 75 HR 16\60 filtration column (flow rate 1 ml\min) equilibrated with 50 mM potassium phosphate, pH 6n8, containing 100 mM KCl, 1 mM DTT, 0n1 mM EDTA and 5 % glycerol (buffer C). Fractions (1 ml) containing the recombinant BPL were pooled and applied to a Pharmacia Hiload TM S HR 16\10 cation-exchange column (flow rate 2n5 ml\min). BPL was eluted with a linear gradient (70 ml) of 0-1n0 M of KCl in buffer C at a flow rate of 2n5 ml\min. Fractions (1 ml) containing the recombinant enzyme were pooled, dialysed against buffer C, concentrated and stored at k80 mC.
Purification of LPL
E. coli BL21(DE3) cells transformed with the plasmid TM202 [24] were grown in LB medium containing 100 µg\ml ampicillin and at an A '!! of 0n6-0n7 were induced with IPTG (final concentration 1 mM) for a further 6 h. The cells were then harvested by centrifugation and resuspended in 10 ml of 50 mM Tris\HCl, pH 7n5, containing 1 mM PMSF, 1 mM EDTA and 10 % glycerol (buffer D). The cells were harvested again by centrifugation and disrupted in a French press. The cell-free extract was applied to a Pharmacia Hiload TM Q HR 16\10 column (flow rate 2n5 ml\min), and the recombinant protein was eluted by applying a linear gradient (100 ml) of NaCl (0-1 M) in buffer A. Fractions (2n5 ml) containing the ligase were concentrated to 1 ml, using a PM10 membrane in an Amicon stirred cell, and applied to a Pharmacia Superdex TM 75 HR 16\60 gel filtration column (flow rate 1 ml\min) equilibrated with buffer D. Fractions of interest (1 ml) were pooled, concentrated and stored at k80 mC.
Expression and purification of E2p lipoyl domain
A recombinant lipoyl domain from E. coli E2p was purified using the expression plasmid pET11cE2p (E. L. Roberts and R. N. Perham, unpublished work). This plasmid is derived from the plasmid pGS233 [33] and carries the sub-gene encoding the innermost of the three lipoyl domains of E. coli E2p [34] under the control of the T7lac promoter in pET11c. E. coli BL21(DE3) cells transformed with pET11cE2p were grown in LB medium containing 100 µg\ml ampicillin and at an A '!! of 0n7-0n8 were induced for expression with IPTG (final concentration 1 mM) for 2 h. Recombinant protein was then purified from the cell-free extract by fractional precipitation with (NH % ) # SO % (30-80 % saturation), followed by gel filtration on a Pharmacia Superdex TM 75 column and ion-exchange chromatography on a Pharmacia Resource TM Q column, essentially as described elsewhere [28] . Reactions were started by the addition of the relevant ligase and were incubated at 22-24 mC for 30 min, unless otherwise stated. After incubation, reactions were subjected to non-denaturing PAGE. The amounts of modified and unmodified domains were determined densitometrically from scanned pictures of the relevant gels using the program Phoretix 1D Advanced (v 3.0).
Lipoylation and biotinylation reactions in vitro
Determination of molecular mass
Molecular masses of recombinant domains were estimated by electrospray (ES)-MS using a VG BioQ quadrapole mass spectrometer and myoglobin as the calibration standard. Proteins for ES-MS were prepared in aqueous solution (salt concentration 2 mM) at a concentration of approx. 5 µM. Samples were diluted in acetonitrile (50 % final concentration) and formic acid (1 % final concentration). Theoretical molecular masses were calculated from the amino acid sequences using the MW\pI computing tool from the ExPasy Database.
General techniques for protein analysis and purification
Protein purifications were carried out on a Pharmacia FPLC TM at 4 mC (unless otherwise stated) and column fractions were analysed by SDS\PAGE (12n5 and 20 % acrylamide) using the Pharmacia PhastSystem TM . The concentrations of pure proteins were estimated by amino acid analysis [35] . Biotinylated and lipoylated forms of the domains were separated by means of nondenaturing PAGE (20 % acrylamide\1 % bis-acrylamide as separating gel ; 5 % acrylamide as stacking gel) using a Tris\ glycine buffer [36] lacking SDS. All gels were stained with Coomassie Brilliant Blue R-250.
RESULTS
Cloning, expression and purification of the wild-type BCCP biotinyl domain
A plasmid, pGwtBCCP, was constructed that encodes a fusion protein with GST at the N-terminus, followed by a thrombin cleavage site and an 82-residue peptide corresponding to the biotinyl domain of the BCCP component of E. coli ACC at the C-terminus. As judged by means of SDS\PAGE and Coomassie Blue staining (results not shown), the fusion protein represented 20-30 % of the total soluble protein in E. coli BL21(DE3) cells after IPTG induction. The biotinyl domain was purified by means of glutathione-Sepharose2 affinity chromatography, thrombin cleavage of the retained fusion protein, followed by filtration of the released biotinyl domain on a Superdex TM 30 column to remove contaminating material (see the Materials and Methods section). The purified domain was found to be at least 98 % pure, as judged from Coomassie-stained 20 % SDS\PAGE gels (results not shown). The average yield of domain was 3 mg\l of E. coli cell culture. N-terminal sequence analysis revealed the expected Gly-Ser sequence generated by the thrombin cleavage, indicating a polypeptide chain of 84 residues in total.
Construction of the mutant biotinyl domains MAK, KAM, KKM, MKK and DKA
The sub-gene encoding the biotinyl domain in pGwtBCCP was subjected to site-directed mutagenesis (see the Materials and Methods section) in the region encoding the highly conserved MKM sequence motif (residues M49, K50 and M51) that embodies the biotinyl-lysine residue (Figure 1 ). Mutant biotinyl domains with the altered sequence motifs MAK, KAM, KKM, MKK and DKA were generated. The KAM and MAK mutants present the target lysine residue for biotinylation moved by one position (to the N-and C-terminal side, respectively) in the β-turn, whereas the MKK and KKM mutants offer two possible target lysine residues in adjacent positions. In the DKA mutant, the target lysine residue is situated in the conserved DKA motif found in the structurally related lipoyl domains [13] .
Post-translational modification of the wild-type and mutant biotinyl domains in vivo
Wild-type and mutant biotinyl domains were purified from E. coli BL21(DE3) cells after induction with IPTG in media supplemented with 10 mg\l d-biotin (see the Materials and Methods section). The purified domains were analysed by means of non-denaturing 20 % PAGE, where the biotinylated form of the domain can be distinguished from the apo-form because it carries one fewer positive charge and therefore migrates more rapidly towards the anode (Figure 2 ). In addition, the proteins were analysed by ES-MS. The molecular mass of the wild-type biotinyl domain was found to be 9204p0n5 Da, 226 Da more than that calculated from the amino acid sequence (8978 Da) and corresponding exactly to that required for the addition of a biotinyl group [37] . The extent of biotinylation of the wild-type domain was over 90 %, as judged by non-denaturing PAGE (Figure 2a) . Thus the wild-type biotinyl domain appears to be almost fully biotinylated in i o under the conditions used. The molecular mass of the putative apo-form was also determined by means of ES-MS after it was separated from the modified form by means of anion-exchange chromatography and, as expected, its molecular mass (8978p0n8 Da) was that calculated from the amino acid sequence.
The MAK and KAM mutant domains, when subjected to non-denaturing PAGE, displayed a single protein band ( Figure  2a ). Their measured molecular masses (MAK 8918p0n6 Da, KAM 8918p0n7 Da) corresponded exactly with those of the apo-forms, as calculated from the amino acid sequences (8918 Da), which indicates that they were not biotinylated in i o. In contrast, the KKM mutant displayed two protein bands of approximately the same intensity in non-denaturing PAGE (Figure 2a ). It also revealed two components on ES-MS, whose molecular masses were those expected for the apo-protein (measured mass 8975p2 Da, expected mass 8975 Da) and the singly biotinylated form of the domain (measured mass 9202p1 Da, expected mass 9201 Da). Thus, under the experimental conditions used (E. coli cells were harvested 3 h after induction in a medium supplemented with biotin), 50 % of the mutant was biotinylated in i o. We could not detect any doubly biotinylated form of the KKM mutant by means of nondenaturing PAGE or ES-MS. Likewise, post-translational modification of the MKK mutant was found to occur in i o, but to be less efficient than that of the KKM mutant. In non-denaturing PAGE ( Figure 2a ) the protein band corresponding to the modified form represented only 10 % of the total domain and its molecular mass (9201p1 Da), as determined by ES-MS, corresponded with that of the singly biotinylated form of the protein (9201 Da). Again, no doubly biotinylated form was detected. The purified DKA mutant domain also contained two components when subjected to non-denaturing PAGE (Figure 2a) , that corresponding to the apo-domain (upper band) representing 90 % of the protein. These two components were purified and analysed by ES-MS. The molecular mass of the upper protein band (8902p1 Da) was that expected for the apo-form of the mutant (8902 Da). The mass spectrum of the lower protein band (Figure 3 ) displayed two products, with molecular masses of 9090 Da and 9030 Da. These mass differences correspond closely with those predicted if the protein had been lipoylated (j188 Da) and octanoylated (j126 Da) respectively. The molar ratio between the putative lipoylated and octanoylated forms of the DKA mutant was approximately 1 : 1 and no biotinylated form of the domain was detectable. The ratio of modified to unmodified form of the DKA mutant did not change significantly when the expression of the relevant mutant was induced in the presence of lipoic acid or octanoic acid instead of d-biotin (Figure 2b) , nor did the proportion of lipoylated to octanoylated form, as judged by ES-MS, under the same conditions (results not shown). However, increasing the time of expression from 3 h (Figure 2a ) to 6 h ( Figure 2b ) was accompanied by an increase of the modified protein band from approx. 10 % to 20 %.
Biotinylation of the biotinyl domains in vitro
Biotinylation of the apo-biotinyl domains was carried out in itro by incubating them with purified BPL under the conditions described in the Materials and Methods section. The extent of biotinylation was analysed by means of non-denaturing PAGE (Figure 4a ) and the results were found to be fully consistent with those obtained in i o. Thus, the MAK or KAM mutants were not biotinylated ; the KKM and MKK mutants were biotinylated but neither of them appeared to be doubly biotinylated ; and the DKA mutant was not biotinylated at all (even if the incubation time was extended to 12 h or more). The concentration of BPL used in these experiments was 0n7 µM, which in preliminary experiments had been found to be sufficient to achieve the complete biotinylation of the wild-type biotinyl domain in 5 min (data not shown). We also studied the biotinylation of the KKM and MKK mutant domains by varying the concentration of BPL in the reaction mixture. Under identical conditions the concentration of ligase needed to biotinylate the KKM and MKK mutants was found to be 2-and 20-fold respectively that required to achieve complete modification of the wild-type biotinyl domain (Figure 4b) .
Lipoylation of the biotinyl domains in vitro
In view of the lipoylation and octanoylation of the DKA biotinyl domain observed in i o, we attempted to lipoylate the domain in itro using the LPL. The concentration of LPL was varied under the conditions described in the Materials and Methods section and the reaction mixtures were analysed by means of non-denaturing PAGE. The DKA mutant was observed not to be lipoylated in 30 min at concentrations of LPL up to 1n8 µM (Figure 5a ), nor did it become detectably lipoylated if the incubation time was increased to 12 h (Figure 5b ). Under identical conditions, the lipoyl domain of E. coli E2p was fully lipoylated in less than 5 min ( Figure 5 ). However, when the concentration of LPL was increased 10-fold or more, lipoylation of the DKA biotinyl domain was significant ( Figure 5, lanes 7 and 8) , but an incubation of more than 12 h was required to bring it to completion (results not shown). This large amount of LPL was also found to be capable of catalysing the lipoylation of the wildtype biotinyl domain to a similar extent (Figure 5c ). In all cases the identities of the products were verified by ES-MS.
DISCUSSION
The biotin cofactor of E. coli acetyl-CoA carboxylase is attached covalently by amide linkage to the N '-amino group of a unique lysine residue of the BCCP component. The attachment is catalysed by BPL as a post-translational modification, and the ligase selects a unique target lysine residue located in a conserved amino acid sequence motif MKM near the tip of a tight β-turn in the structure of the biotinyl domain (Figure 1 ). Li and Cronan [3] were the first to show that fusion of the C-terminal 84 amino acids of BCCP to β-galactosidase led to the production of biotinylated β-galactosidase molecules in i o. However, the expression level of this fusion protein was low. Chapman-Smith et al. [5] have also reported the expression of a sub-gene in E. coli encoding the C-terminal 87 residues of the E. coli BCCP, generating a partly biotinylated protein in i o. As pointed out by these authors, the production of the peptide, where expression was under the control of the T7 promoter of pET, appeared to have saturated the capacity of the intracellular BPL. The GST-biotinyl domain fusion that we have used allows the preparation of a biotinyl domain that has been biotinylated to a large extent (90 % or more) in i o under the conditions used (supplementing the growth medium with 10 mg\l d-biotin). A small amount of apo-domain (Figure 2 ) could be separated from the biotinylated form by ion-exchange chromatography.
The presentation of the target lysine residue in the structure of the biotinyl domain is evidently of crucial importance for the biotinylation reaction. Thus, the KAM and MAK mutant domains, with the lysine residue moved one position to the Nand C-terminal side respectively, were not biotinylated either in i o (Figure 2 ) or in itro (Figure 4 ) and the KKM or MKK mutant domains, with two potential sites for biotinylation, were found to be biotinylated at only one site. Given the results with the KAM and MAK mutants, it is reasonable to suppose that this is the lysine residue in its normal position, though this has not been formally proved by amino acid sequence analysis. Thus, as with lipoylation of the lipoyl domain from 2-oxo acid dehydrogenase multienzyme complexes where a full sequence analysis was carried out [29] , it clearly is essential for the target lysine residue to be properly positioned in the hairpin loop on the surface of the biotinyl domain for post-translational modification to occur. However, the biotinylation of the KKM and MKK mutant domains, although it occurred, was significantly impaired. Under identical conditions in i o, the modification of the KKM mutant reached 50 % of that of the wild-type domain and that of the MKK mutant only 10 %. The DKA mutant domain was not biotinylated at all. Similar results were obtained when the biotinylation of the various domains by purified BPL was examined in itro ( Figure 4 ). Thus it would appear that the methionine residues flanking the target lysine form part of the surface of the biotinyl domain that is recognized by BPL. None the less, although the MKM motif for the biotinylated lysine residue is highly conserved in all biotinylated proteins [8] , it is not sufficient to ensure biotinylation. This is clear from the observation that importing the MKM motif into the lipoyl domain of Bacillus stearothermophilus pyruvate dehydrogenase complex leaves it capable of being lipoylated but does not render it a substrate for biotinylation in i o in E. coli [29] .
Replacement of the methionine residues flanking the target lysine with leucine on the biotinyl domain of the α-subunit from human propionyl-CoA carboxylase [38] and the 1n3 S subunit of Pseudomonas shermanii transcarboxylase [39] has demonstrated that the methionine residues are not essential for correct biotinylation of these proteins in i o by E. coli BPL. However, in the P. shermanii transcarboxylase, further analysis showed the subsequent carboxylation of the biotin moiety to be defective [40] . Taking these data together with our own results, it appears that methionine residues flanking the target lysine residue may have been evolutionarily selected in order to be compatible with the interaction first with the BPL and subsequently with the relevant carboxylase. Further investigation of the effects of systematic exchange of the methionine residues on the biotinylation and carboxylation reactions will be necessary to understand these protein-protein interactions and their needs for compatibility in more detail.
Previous studies of the lipoylation of the lipoyl domain from the pyruvate dehydrogenase multienzyme complex of B. stearothermophilus in E. coli indicated that the conserved aspartic acid and alanine residues surrounding the target lysine residue (the DKA motif) are not essential for lipoylation, but that the correct positioning of the lysine at the tip of the tight β-turn in the domain is crucial [29] . The DKA motif is replaced by DKV in the lipoyl domains of the 2-oxoglutarate dehydrogenase complexes of E. coli [15, 41] and Azobacter inelandii [16] , by AKA in the N-terminal lipoyl domain of the pyruvate dehydrogenase complex of A. inelandii [17] , and by VKA in the lipoylated H-protein of the glycine decarboxylase complex of ox [42] , pea leaf [43, 44] and E. coli [45] . None the less, all these domains can be lipoylated in i o in E. coli. Thus, we were surprised to find that the DKA mutant biotinyl domain was lipoylated and octanoylated in i o, albeit at a low level (Figures 2 and 3) . Octanoylation of lipoyl domains as an aberrant modification in i o, under conditions of lipoic acid deficiency [27] or where over-expression of the lipoyl domain swamps the lipoylating machinery of the E. coli cell, has been observed before [28, 42] .
It would appear that the DKA motif, when displayed at the right position in a structurally related protein, is sufficient to direct lipoylation of the target lysine residue in i o. This is in contrast with the lack of lipoylation of the lipoyl domain of the bovine branched-chain 2-oxo acid dehydrogenase complex, which also exhibits the DKA motif, expressed in E. coli [46] . It is significant that the lipoylation of the DKA biotinyl domain catalysed by the purified E. coli LPL in itro, although it took place, was very slow. Indeed, it was not very different from the lipoylation of the wild-type biotinyl domain under forcing conditions (stoichiometric amounts of domain and ligase) in itro ( Figure 5 ). This may indicate that the post-translational modification of the DKA mutant domain in i o is catalysed by an enzyme different from the purified LPL used here, the product of the lplA gene [24] . That enzyme could be the lipB-dependent LPL, which is believed to be responsible for most of the octanoylation occurring in i o [23] . However, it cannot be discounted that the lipoylation of the DKA mutant observed in i o could also be due, at least in part, to the product of the lplA gene under the conditions of high level expression of the domain. Overall, it is apparent that lipoylation and biotinylation of the relevant protein domains do not rely simply on the recognition of unique and well-conserved sequence motifs. Instead, the recognition process between the domain and its cognate ligase has a major structural component to it, notably the positioning of the target lysine residue in the exposed hairpin loop in one of the two β-sheets that make up the domains, together with additional recognition sites elsewhere on the domains. This emerging position has been somewhat clouded recently by the observation that a 13-residue peptide tag can be added to proteins that appears to target biotinylation by BPL to a lysine residue embedded in it [47, 48] . Whether this peptide has any persistent structure in solution, and if so whether it resembles the β-turn that houses the biotinylated lysine residue in native proteins, is unknown. How these recognition processes function at the molecular level remains an important problem to be solved in detail.
